Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Medtronic plcMDT · Entity 2888 | EVP, Chief HR Officer | August 01, 2022 | August 03, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Medtronic plc
Report date August 01, 2022 · Filed August 03, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 26,193 |
Reported balance
After 2022-08-01 transaction · row 1
1 source rowRow 1 · 2022-08-01 · Grant · Acquired 5,157 · Balance 26,193 F1: The restrictions on the award shall lapse 100% on the third anniversary of the Grant Date. |
| Performance Share UnitsSEC Table II · derivative / convertible security | Direct | 12,893 |
Reported balance
After 2022-08-01 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2022-08-01 · Grant · Acquired 12,893 · Balance 12,893 F2: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F3: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 12,893 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares. F4: Vests on August 1, 2025. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $93.08 · Expires 2032-08-01 | Direct | 40,754 |
Reported balance
After 2022-08-01 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2022-08-01 · Grant · Acquired 40,754 · Balance 40,754 F5: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. |
| Ordinary SharesSEC Table I · non-derivative | IndirectNQ Ret Plan Sup | 576 |
Reported balance
Holding disclosure · report date 2022-08-01 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 576 |
Filing footnotes · ownership attribution and instrument terms
F1: The restrictions on the award shall lapse 100% on the third anniversary of the Grant Date.
F2: Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
F3: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 12,893 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
F4: Vests on August 1, 2025.
F5: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 01, 2022 Filed Aug 3, 2022 17:34 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 40,754 | $0.00 Strike: $93.08 | $0.00 |
DisclosureSEC source: 0001127602-22-020412 · form4.xml · derivative · entry 4 Surface Carol A · CIK 0001485966 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,754 Underlying: Ordinary Shares · 40,754 shares Expires 2032-08-01 F5 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| August 01, 2022 Filed Aug 3, 2022 17:34 UTC | Medtronic plc MDT · Entity 2888 | GrantPerformance Share Units · Derivative | 12,893 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-020412 · form4.xml · derivative · entry 3 Surface Carol A · CIK 0001485966 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,893 Underlying: Performance Share Units · 12,893 shares Expires not disclosed F2 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F3 · shares: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 12,893 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares. F4 · derivative.exercise_date: Vests on August 1, 2025. F4 · derivative.expiration_date: Vests on August 1, 2025. Read SEC document |
| August 01, 2022 Filed Aug 3, 2022 17:34 UTC | Medtronic plc MDT · Entity 2888 | GrantOrdinary Shares | 5,157 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-020412 · form4.xml · nonDerivative · entry 1 Surface Carol A · CIK 0001485966 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,193 F1 · shares: The restrictions on the award shall lapse 100% on the third anniversary of the Grant Date. Read SEC document |
| July 29, 2022 Filed Aug 2, 2022 17:33 UTC | Medtronic plc MDT · Entity 2888 | Disposition to issuerOrdinary Shares | 7,920 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-020210 · form4.xml · nonDerivative · entry 1 Surface Carol A · CIK 0001485966 · EVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,036 F1 · shares: Represents shares of performance-vesting restricted stock granted in July 2019 and earned dividend equivalent units that have been forfeited based on the Company's failure to meet the cumulative three year non-GAAP diluted earnings per share ("EPS") growth performance target. F2 · balance_after: This balance increased by 454 shares due to exempt transactions such as dividend reinvestment and employee stock purchase plan. Read SEC document |
| March 11, 2022 Filed Mar 14, 2022 17:46 UTC | Medtronic plc MDT · Entity 2888 | SaleOrdinary Shares | 6,000 | $105.30 | $631,800.00 |
DisclosureSEC source: 0001127602-22-009166 · form4.xml · nonDerivative · entry 1 Surface Carol A · CIK 0001485966 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,502 F1 · balance_after: This balance increased by 175 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 18:25 UTC | Medtronic plc MDT · Entity 2888 | GrantPerformance Share Units · Derivative | 9,143 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-023106 · form4.xml · derivative · entry 6 Surface Carol A · CIK 0001485966 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,143 Underlying: Performance Share Units · 9,143 shares Expires not disclosed F5 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F6 · shares: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 9,143 shares will be issued. The actual number of shares to be issued could range from a low of 1,829 at minimum performance to a high of 18,286 shares at maximum performance. If minimum performance metrics are not met, such PSUs may vest at 0 shares. F7 · derivative.exercise_date: Vests on August 2, 2024. F7 · derivative.expiration_date: Vests on August 2, 2024. Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 18:25 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 1,085 | $0.00 Strike: $131.26 | $0.00 |
DisclosureSEC source: 0001127602-21-023106 · form4.xml · derivative · entry 5 Surface Carol A · CIK 0001485966 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,085 Underlying: Ordinary Shares · 1,085 shares Expires 2031-08-02 F4 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 18:25 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 31,245 | $0.00 Strike: $131.26 | $0.00 |
DisclosureSEC source: 0001127602-21-023106 · form4.xml · derivative · entry 4 Surface Carol A · CIK 0001485966 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,245 Underlying: Ordinary Shares · 31,245 shares Expires 2031-08-02 F4 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 18:25 UTC | Medtronic plc MDT · Entity 2888 | GrantOrdinary Shares | 3,657 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-023106 · form4.xml · nonDerivative · entry 2 Surface Carol A · CIK 0001485966 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,327 F2 · kind: The restrictions on the award shall lapse 100% on the third anniversary of the Grant Date. Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 18:25 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 3,997 | $131.31 | $524,846.07 |
DisclosureSEC source: 0001127602-21-023106 · form4.xml · nonDerivative · entry 1 Surface Carol A · CIK 0001485966 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,670 F1 · balance_after: This balance increased by 517 shares due to exempt transactions such as dividend reinvestment and employee stock purchase plan. Read SEC document |
| December 28, 2020 Filed Dec 30, 2020 16:42 UTC | Medtronic plc MDT · Entity 2888 | SaleOrdinary Shares | 15,000 | $114.90 | $1,723,500.00 |
DisclosureSEC source: 0001127602-20-032568 · form4.xml · nonDerivative · entry 1 Surface Carol A · CIK 0001485966 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,150 F1 · price: The price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.87 to $115.01, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes to this Form 4. F2 · balance_after: This balance increased by 110 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| October 09, 2020 Filed Oct 14, 2020 19:04 UTC | Medtronic plc MDT · Entity 2888 | GrantPerformance Share Units · Derivative | 10,582 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-026960 · form4.xml · derivative · entry 1 Surface Carol A · CIK 0001485966 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,582 Underlying: Performance Share Units · 10,582 shares Expires not disclosed F1 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F2 · shares: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 10,582 shares will be issued. The actual number of shares to be issued could range from a low of 2,117 at minimum performance to a high of 21,164 shares at maximum performance. If minimum performance metrics are not met, such PSUs may vest at 0 shares. F3 · derivative.exercise_date: Vests on August 3, 2023. F3 · derivative.expiration_date: Vests on August 3, 2023. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 17:08 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 34,005 | $0.00 Strike: $97.33 | $0.00 |
DisclosureSEC source: 0001127602-20-022922 · form4.xml · derivative · entry 5 Surface Carol A · CIK 0001485966 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,005 Underlying: Ordinary Shares · 34,005 shares Expires 2030-08-03 F3 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 17:08 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 1,575 | $0.00 Strike: $97.33 | $0.00 |
DisclosureSEC source: 0001127602-20-022922 · form4.xml · derivative · entry 4 Surface Carol A · CIK 0001485966 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,575 Underlying: Ordinary Shares · 1,575 shares Expires 2030-08-03 F3 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 17:08 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 43,451 | $0.00 Strike: $97.33 | $0.00 |
DisclosureSEC source: 0001127602-20-022922 · form4.xml · derivative · entry 3 Surface Carol A · CIK 0001485966 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,451 Underlying: Ordinary Shares · 43,451 shares Expires 2030-08-03 F3 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 17:08 UTC | Medtronic plc MDT · Entity 2888 | GrantOrdinary Shares | 4,727 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-022922 · form4.xml · nonDerivative · entry 1 Surface Carol A · CIK 0001485966 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,040 F1 · kind: The restrictions on these restricted stock units shall lapse 100% on the third anniversary of the Grant Date. Read SEC document |
| July 31, 2020 Filed Aug 3, 2020 18:02 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 3,554 | $96.48 | $342,889.92 |
DisclosureSEC source: 0001127602-20-022608 · form4.xml · nonDerivative · entry 1 Surface Carol A · CIK 0001485966 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,313 F1 · balance_after: This balance increased by 424 shares due to exempt transactions such as dividend reinvestment and employee stock purchase plan. Read SEC document |
| May 29, 2020 Filed Jun 2, 2020 17:39 UTC | Medtronic plc MDT · Entity 2888 | SaleOrdinary Shares | 2,000 | $97.72 | $195,440.00 |
DisclosureSEC source: 0001127602-20-018500 · form4.xml · nonDerivative · entry 1 Surface Carol A · CIK 0001485966 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,443 F1 · balance_after: This balance increased by 371 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| October 11, 2019 Filed Oct 15, 2019 16:37 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionStock Option (Right to Buy) · Derivative | 17,466 | $0.00 Strike: $83.97 | $0.00 |
DisclosureSEC source: 0001127602-19-030510 · form4.xml · derivative · entry 11 Surface Carol A · CIK 0001485966 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,468 Underlying: Ordinary Shares · 17,466 shares Expires 2027-07-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: These options to purchase ordinary shares of New Medtronic for $62.76 per share, which were unvested at the effective time of the Merger, were received in the Merger and represent the conversion of an equal number of Medtronic common stock shares for $62.76 per share. The New Medtronic stock option has the same terms and conditions as the original Medtronic stock option. These options became exercisable in four equal annual installments beginning on July 28, 2015, which was the first anniversary of the grant. Read SEC document |
| October 11, 2019 Filed Oct 15, 2019 16:37 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionStock Option (Right to Buy) · Derivative | 24,983 | $0.00 Strike: $88.06 | $0.00 |
DisclosureSEC source: 0001127602-19-030510 · form4.xml · derivative · entry 10 Surface Carol A · CIK 0001485966 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,328 Underlying: Ordinary Shares · 24,983 shares Expires 2026-08-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: These options to purchase ordinary shares of New Medtronic for $62.76 per share, which were unvested at the effective time of the Merger, were received in the Merger and represent the conversion of an equal number of Medtronic common stock shares for $62.76 per share. The New Medtronic stock option has the same terms and conditions as the original Medtronic stock option. These options became exercisable in four equal annual installments beginning on July 28, 2015, which was the first anniversary of the grant. Read SEC document |
| October 11, 2019 Filed Oct 15, 2019 16:37 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionStock Option (Right to Buy) · Derivative | 34,189 | $0.00 Strike: $78.00 | $0.00 |
DisclosureSEC source: 0001127602-19-030510 · form4.xml · derivative · entry 9 Surface Carol A · CIK 0001485966 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,283 Underlying: Ordinary Shares · 34,189 shares Expires 2025-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| October 11, 2019 Filed Oct 15, 2019 16:37 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionStock Option (Right to Buy) · Derivative | 7,569 | $0.00 Strike: $62.76 | $0.00 |
DisclosureSEC source: 0001127602-19-030510 · form4.xml · derivative · entry 8 Surface Carol A · CIK 0001485966 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 399 Underlying: Ordinary Shares · 7,569 shares Expires 2024-07-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option to purchase 1,594 New Medtronic ordinary shares for $62.76 per share, which was unvested at the effective time of the Merger, was received in the Merger and represents the conversion of 1,594 Medtronic common stock shares for $62.76 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option. F4 · derivative.exercise_date: This option to purchase 30,275 New Medtronic ordinary shares for $62.76 per share, which was unvested at the effective time of the Merger, was received in the Merger and represents the conversion of 30,275 Medtronic common stock shares for $62.76 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option. Read SEC document |
| October 11, 2019 Filed Oct 15, 2019 16:37 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 72,848 | $107.58 | $7,836,987.84 |
DisclosureSEC source: 0001127602-19-030510 · form4.xml · nonDerivative · entry 5 Surface Carol A · CIK 0001485966 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,072 Read SEC document |
| October 11, 2019 Filed Oct 15, 2019 16:37 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionOrdinary Shares | 17,466 | $83.97 | $1,466,620.02 |
DisclosureSEC source: 0001127602-19-030510 · form4.xml · nonDerivative · entry 4 Surface Carol A · CIK 0001485966 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,920 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 11, 2019 Filed Oct 15, 2019 16:37 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionOrdinary Shares | 24,983 | $88.06 | $2,200,002.98 |
DisclosureSEC source: 0001127602-19-030510 · form4.xml · nonDerivative · entry 3 Surface Carol A · CIK 0001485966 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,454 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 11, 2019 Filed Oct 15, 2019 16:37 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionOrdinary Shares | 34,189 | $78.00 | $2,666,742.00 |
DisclosureSEC source: 0001127602-19-030510 · form4.xml · nonDerivative · entry 2 Surface Carol A · CIK 0001485966 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,471 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 11, 2019 Filed Oct 15, 2019 16:37 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionOrdinary Shares | 7,569 | $62.76 | $475,030.44 |
DisclosureSEC source: 0001127602-19-030510 · form4.xml · nonDerivative · entry 1 Surface Carol A · CIK 0001485966 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,282 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2019 Filed Aug 2, 2019 18:42 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 4,058 | $102.37 | $415,417.46 |
DisclosureSEC source: 0001127602-19-025939 · form4.xml · nonDerivative · entry 1 Surface Carol A · CIK 0001485966 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,713 Read SEC document |
| July 29, 2019 Filed Jul 31, 2019 18:11 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 1,615 | $0.00 Strike: $103.26 | $0.00 |
DisclosureSEC source: 0001127602-19-025562 · form4.xml · derivative · entry 5 Surface Carol A · CIK 0001485966 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,615 Underlying: Ordinary Shares · 1,615 shares Expires 2029-07-29 F3 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| July 29, 2019 Filed Jul 31, 2019 18:11 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 49,523 | $0.00 Strike: $103.26 | $0.00 |
DisclosureSEC source: 0001127602-19-025562 · form4.xml · derivative · entry 4 Surface Carol A · CIK 0001485966 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,523 Underlying: Ordinary Shares · 49,523 shares Expires 2029-07-29 F3 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| July 29, 2019 Filed Jul 31, 2019 18:11 UTC | Medtronic plc MDT · Entity 2888 | GrantOrdinary Shares | 7,425 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-025562 · form4.xml · nonDerivative · entry 1 Surface Carol A · CIK 0001485966 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,771 F1 · kind: The restrictions on these restricted stock units shall lapse 100% on the third anniversary of the Grant Date if the Company's cumulative non-GAAP diluted earnings per share ("EPS") growth during the 36-month period ending on the last day of the Company's fiscal year 2022 equals or exceeds a 3% cumulative compound annual growth rate, as determined by the Compensation Committee. F2 · balance_after: This balance increased by 188 shares due to exempt transactions such as dividend reinvestment and employee stock purchase plan. Read SEC document |
| June 17, 2019 Filed Jun 18, 2019 17:31 UTC | Medtronic plc MDT · Entity 2888 | SaleOrdinary Shares | 9,000 | $97.66 | $878,976.00 |
DisclosureSEC source: 0001127602-19-022044 · form4.xml · nonDerivative · entry 1 Surface Carol A · CIK 0001485966 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,158 F1 · balance_after: This balance increased by 659 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| August 03, 2018 Filed Aug 7, 2018 16:40 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 4,156 | $90.48 | $376,034.88 |
DisclosureSEC source: 0001127602-18-024851 · form4.xml · nonDerivative · entry 1 Surface Carol A · CIK 0001485966 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,499 Read SEC document |
| July 30, 2018 Filed Aug 1, 2018 16:04 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 1,695 | $0.00 Strike: $89.08 | $0.00 |
DisclosureSEC source: 0001127602-18-024248 · form4.xml · derivative · entry 5 Surface Carol A · CIK 0001485966 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,695 Underlying: Ordinary Shares · 1,695 shares Expires 2028-07-30 F3 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| July 30, 2018 Filed Aug 1, 2018 16:04 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 49,707 | $0.00 Strike: $89.08 | $0.00 |
DisclosureSEC source: 0001127602-18-024248 · form4.xml · derivative · entry 4 Surface Carol A · CIK 0001485966 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,707 Underlying: Ordinary Shares · 49,707 shares Expires 2028-07-30 F3 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| July 30, 2018 Filed Aug 1, 2018 16:04 UTC | Medtronic plc MDT · Entity 2888 | GrantOrdinary Shares | 8,233 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-024248 · form4.xml · nonDerivative · entry 1 Surface Carol A · CIK 0001485966 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,654 F1 · kind: The restrictions on these restricted stock units shall lapse 100% on the third anniversary of the Grant Date if the Company's cumulative non-GAAP diluted earnings per share ("EPS") growth during the 36-month period ending on the last day of the Company's fiscal year 2021 equals or exceeds a 3% cumulative compound annual growth rate, as determined by the Compensation Committee. F2 · balance_after: This balance increased by 211 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| June 22, 2018 Filed Jul 6, 2018 16:41 UTC | Medtronic plc MDT · Entity 2888 | OtherOrdinary Shares | 265 | $86.81 | $23,004.65 |
DisclosureSEC source: 0001127602-18-022929 · form4.xml · nonDerivative · entry 2 Surface Carol A · CIK 0001485966 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Indirect · NQ Ret Plan Sup Disclosed balance after: 532 F1 · security: This balance was previously incorrectly included in the 401(k) balance. Read SEC document |
| June 22, 2018 Filed Jul 6, 2018 16:41 UTC | Medtronic plc MDT · Entity 2888 | OtherOrdinary Shares | 720 | $86.81 | $62,503.20 |
DisclosureSEC source: 0001127602-18-022929 · form4.xml · nonDerivative · entry 1 Surface Carol A · CIK 0001485966 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Indirect · 401(k) Disclosed balance after: 1,560 Read SEC document |
| March 05, 2018 Filed Mar 6, 2018 16:09 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,195 | $0.00 Strike: $62.76 | $0.00 |
DisclosureSEC source: 0001127602-18-010338 · form4.xml · derivative · entry 10 Surface Carol A · CIK 0001485966 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,374 Underlying: Ordinary Shares · 1,195 shares Expires 2024-07-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option to purchase 1,594 New Medtronic ordinary shares for $62.76 per share, which was unvested at the effective time of the Merger, was received in the Merger and represents the conversion of 1,594 Medtronic common stock shares for $62.76 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option. F5 · derivative.exercise_date: This option to purchase 30,275 New Medtronic ordinary shares for $62.76 per share, which was unvested at the effective time of the Merger, was received in the Merger and represents the conversion of 30,275 Medtronic common stock shares for $62.76 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option. Read SEC document |
| March 05, 2018 Filed Mar 6, 2018 16:09 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionStock Option (Right to Buy) · Derivative | 22,706 | $0.00 Strike: $62.76 | $0.00 |
DisclosureSEC source: 0001127602-18-010338 · form4.xml · derivative · entry 9 Surface Carol A · CIK 0001485966 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,569 Underlying: Ordinary Shares · 22,706 shares Expires 2024-07-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option to purchase 1,594 New Medtronic ordinary shares for $62.76 per share, which was unvested at the effective time of the Merger, was received in the Merger and represents the conversion of 1,594 Medtronic common stock shares for $62.76 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option. F5 · derivative.exercise_date: This option to purchase 30,275 New Medtronic ordinary shares for $62.76 per share, which was unvested at the effective time of the Merger, was received in the Merger and represents the conversion of 30,275 Medtronic common stock shares for $62.76 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option. Read SEC document |
| March 05, 2018 Filed Mar 6, 2018 16:09 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionStock Option (Right to Buy) · Derivative | 24,719 | $0.00 Strike: $57.65 | $0.00 |
DisclosureSEC source: 0001127602-18-010338 · form4.xml · derivative · entry 8 Surface Carol A · CIK 0001485966 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,239 Underlying: Ordinary Shares · 24,719 shares Expires 2023-10-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option to purchase 32,958 New Medtronic ordinary shares for $57.65 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 32,958 Medtronic common stock shares for $57.65 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option. Read SEC document |
| March 05, 2018 Filed Mar 6, 2018 16:09 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 40,338 | $79.74 | $3,216,552.12 |
DisclosureSEC source: 0001127602-18-010338 · form4.xml · nonDerivative · entry 6 Surface Carol A · CIK 0001485966 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,813 Read SEC document |
| March 05, 2018 Filed Mar 6, 2018 16:09 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionOrdinary Shares | 1,195 | $62.76 | $74,998.20 |
DisclosureSEC source: 0001127602-18-010338 · form4.xml · nonDerivative · entry 5 Surface Carol A · CIK 0001485966 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,151 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 05, 2018 Filed Mar 6, 2018 16:09 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionOrdinary Shares | 22,706 | $62.76 | $1,425,028.56 |
DisclosureSEC source: 0001127602-18-010338 · form4.xml · nonDerivative · entry 4 Surface Carol A · CIK 0001485966 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,956 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 05, 2018 Filed Mar 6, 2018 16:09 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionOrdinary Shares | 24,719 | $57.65 | $1,425,050.35 |
DisclosureSEC source: 0001127602-18-010338 · form4.xml · nonDerivative · entry 3 Surface Carol A · CIK 0001485966 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 05, 2018 Filed Mar 6, 2018 16:09 UTC | Medtronic plc MDT · Entity 2888 | SaleOrdinary Shares | 12,479 | $78.36 | $977,854.44 |
DisclosureSEC source: 0001127602-18-010338 · form4.xml · nonDerivative · entry 2 Surface Carol A · CIK 0001485966 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,531 F2 · price: The price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.340 to $78.440, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes to this Form 4. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 16:09 UTC | Medtronic plc MDT · Entity 2888 | SaleOrdinary Shares | 12,000 | $78.00 | $936,000.00 |
DisclosureSEC source: 0001127602-18-010338 · form4.xml · nonDerivative · entry 1 Surface Carol A · CIK 0001485966 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,010 F1 · balance_after: This balance increased by 140 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| October 28, 2017 Filed Oct 31, 2017 15:41 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 8,602 | $81.30 | $699,342.60 |
DisclosureSEC source: 0001127602-17-030603 · form4.xml · nonDerivative · entry 1 Surface Carol A · CIK 0001485966 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,871 F1 · balance_after: This balance increased by 258 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 14:55 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 1,191 | $0.00 Strike: $83.97 | $0.00 |
DisclosureSEC source: 0001127602-17-024705 · form4.xml · derivative · entry 4 Surface Carol A · CIK 0001485966 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,191 Underlying: Ordinary Shares · 1,191 shares Expires 2027-07-31 F2 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 14:55 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 34,934 | $0.00 Strike: $83.97 | $0.00 |
DisclosureSEC source: 0001127602-17-024705 · form4.xml · derivative · entry 3 Surface Carol A · CIK 0001485966 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,934 Underlying: Ordinary Shares · 34,934 shares Expires 2027-07-31 F2 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.